373 related articles for article (PubMed ID: 12493116)
21. Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells.
Roth W; Wild-Bode C; Platten M; Grimmel C; Melkonyan HS; Dichgans J; Weller M
Oncogene; 2000 Aug; 19(37):4210-20. PubMed ID: 10980594
[TBL] [Abstract][Full Text] [Related]
22. Dexamethasone inhibits glioma-induced formation of capillary like structures in vitro and angiogenesis in vivo.
Wolff JE; Mölenkamp G; Hotfilder M; Laterra J
Klin Padiatr; 1997; 209(4):275-7. PubMed ID: 9293462
[TBL] [Abstract][Full Text] [Related]
23. A selective cyclic integrin antagonist blocks the integrin receptors alphavbeta3 and alphavbeta5 and inhibits retinal pigment epithelium cell attachment, migration and invasion.
Hoffmann S; He S; Jin M; Ehren M; Wiedemann P; Ryan SJ; Hinton DR
BMC Ophthalmol; 2005 Jun; 5():16. PubMed ID: 15987521
[TBL] [Abstract][Full Text] [Related]
24. RGD binding to integrin alphavbeta3 affects cell motility and adhesion in primary human breast cancer cultures.
Georgoulis A; Havaki S; Drosos Y; Goutas N; Vlachodimitropoulos D; Aleporou-Marinou V; Kittas C; Marinos E; Kouloukoussa M
Ultrastruct Pathol; 2012 Dec; 36(6):387-99. PubMed ID: 23181508
[TBL] [Abstract][Full Text] [Related]
25. Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma.
Bello L; Lucini V; Costa F; Pluderi M; Giussani C; Acerbi F; Carrabba G; Pannacci M; Caronzolo D; Grosso S; Shinkaruk S; Colleoni F; Canron X; Tomei G; Deleris G; Bikfalvi A
Clin Cancer Res; 2004 Jul; 10(13):4527-37. PubMed ID: 15240545
[TBL] [Abstract][Full Text] [Related]
26. Human malignant glioma therapy using anti-alpha(v)beta3 integrin agents.
Chatterjee S; Matsumura A; Schradermeier J; Gillespie GY
J Neurooncol; 2000; 46(2):135-44. PubMed ID: 10894366
[TBL] [Abstract][Full Text] [Related]
27. An integrin αvβ3 antagonistic modified peptide inhibits tumor growth through inhibition of the ERK and AKT signaling pathways.
Hu L; Wang J; Wang Y; Xu H
Oncol Rep; 2016 Oct; 36(4):1953-62. PubMed ID: 27499314
[TBL] [Abstract][Full Text] [Related]
28. Combined inhibition of vascular endothelial growth factor and platelet-derived growth factor signaling: effects on the angiogenesis, microcirculation, and growth of orthotopic malignant gliomas.
Farhadi MR; Capelle HH; Erber R; Ullrich A; Vajkoczy P
J Neurosurg; 2005 Feb; 102(2):363-70. PubMed ID: 15739567
[TBL] [Abstract][Full Text] [Related]
29. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
[TBL] [Abstract][Full Text] [Related]
30. Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness.
Saidi A; Hagedorn M; Allain N; Verpelli C; Sala C; Bello L; Bikfalvi A; Javerzat S
Int J Cancer; 2009 Sep; 125(5):1054-64. PubMed ID: 19431143
[TBL] [Abstract][Full Text] [Related]
31. Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC.
Vajkoczy P; Menger MD; Goldbrunner R; Ge S; Fong TA; Vollmar B; Schilling L; Ullrich A; Hirth KP; Tonn JC; Schmiedek P; Rempel SA
Int J Cancer; 2000 Jul; 87(2):261-8. PubMed ID: 10861485
[TBL] [Abstract][Full Text] [Related]
32. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
[TBL] [Abstract][Full Text] [Related]
33. Integrin alphavbeta3 is not significantly implicated in the anti-migratory effect of anti-angiogenic urokinase kringle domain.
O E; Kim HK; Hong SH; Kim CK; Hong YK; Joe YA
Oncol Rep; 2008 Sep; 20(3):631-6. PubMed ID: 18695916
[TBL] [Abstract][Full Text] [Related]
34. RGD-labeled USPIO inhibits adhesion and endocytotic activity of alpha v beta3-integrin-expressing glioma cells and only accumulates in the vascular tumor compartment.
Kiessling F; Huppert J; Zhang C; Jayapaul J; Zwick S; Woenne EC; Mueller MM; Zentgraf H; Eisenhut M; Addadi Y; Neeman M; Semmler W
Radiology; 2009 Nov; 253(2):462-9. PubMed ID: 19789239
[TBL] [Abstract][Full Text] [Related]
35. Coadministration of sorafenib with rottlerin potently inhibits cell proliferation and migration in human malignant glioma cells.
Jane EP; Premkumar DR; Pollack IF
J Pharmacol Exp Ther; 2006 Dec; 319(3):1070-80. PubMed ID: 16959960
[TBL] [Abstract][Full Text] [Related]
36. Angiostatin suppresses malignant glioma growth in vivo.
Kirsch M; Strasser J; Allende R; Bello L; Zhang J; Black PM
Cancer Res; 1998 Oct; 58(20):4654-9. PubMed ID: 9788618
[TBL] [Abstract][Full Text] [Related]
37. ABT-510, a modified type 1 repeat peptide of thrombospondin, inhibits malignant glioma growth in vivo by inhibiting angiogenesis.
Anderson JC; Grammer JR; Wang W; Nabors LB; Henkin J; Stewart JE; Gladson CL
Cancer Biol Ther; 2007 Mar; 6(3):454-62. PubMed ID: 17384534
[TBL] [Abstract][Full Text] [Related]
38. Long-term inhibition of glioma growth by systemic administration of human PEX.
Pluderi M; Lucini V; Caronzolo D; Pannacci M; Costa F; Carrabba G; Giussani C; Grosso S; Colleoni F; Scaglione F; Villani R; Bikfalvi A; Bello L
J Neurosurg Sci; 2003 Jun; 47(2):69-78. PubMed ID: 14618134
[TBL] [Abstract][Full Text] [Related]
39. Ligands for mapping alphavbeta3-integrin expression in vivo.
Schottelius M; Laufer B; Kessler H; Wester HJ
Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
[TBL] [Abstract][Full Text] [Related]
40. Alphaxalone inhibits growth, migration and invasion of rat C6 malignant glioma cells.
Sun H; Zheng X; Zhou Y; Zhu W; Ou Y; Shu M; Gao X; Leng T; Qiu P; Yan G
Steroids; 2013 Oct; 78(10):1041-5. PubMed ID: 23831782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
